Patient protection starts before someone arrives at a study site. From the first recruitment advertisement to being consented and randomized with site staff, the way information is communicated, collected, and handled helps shape a patient’s experience and willingness to participate in a clinical trial.
For sponsors, this makes clear communication, responsible data handling, and effective quality oversight essential considerations when choosing a recruitment vendor. To mark World Patient Safety Day on September 17th, we look at how Clariness puts these responsibilities into practice through ClinLife®, and the processes and evidence behind them.
To understand this better, we sat down with our Head of Quality & Compliance and Pharmacovigilance (PVI), Maria Pogoda, and she told us four key ways we ensure patient data and privacy are handled with the utmost importance as part of ClinLife®, from the information patients first encounter to the processes supporting their enrollment experience.
1. Protecting patients’ personal data and privacy
Exploring a clinical trial can require patients to share sensitive information about their diagnosis or treatment history. That makes privacy more than a technical requirement – it is part of the trust patients place in the recruitment process.
Through ClinLife®, documented patient consent is obtained before personal or health-related information is processed. Consent records are time-stamped and linked to the country-relevant privacy notice and practices. Patients can also exercise rights regarding their information, including requesting access, correction or deletion, or withdrawing consent where applicable.
Access to patient-identifiable information is restricted to authorized Clariness teams involved in the patient journey. Permissions are role-based, logged, and regularly reviewed, and patient-identifiable information collected through ClinLife® is never shared directly with sponsors. Only anonymized recruitment insights and reporting are shared with sponsors, built on data in a separate environment to ensure nothing can leak into sponsor-facing areas
We also apply data minimization; pre-qualification screener questions are designed to collect only information necessary to assess a potential trial match and support the next step. A screener might ask about a particular diagnosis or treatment history without requesting someone’s complete medical history, for example.
This means that privacy is considered in both what we ask, and how we handle the data patients consent to providing.
2. Independently reviewed, patient-friendly study communication
Clear, trustworthy study information helps patients make informed decisions about whether a clinical trial may be right for them. Study-specific information presented through ClinLife® undergoes all required independent ethics committee reviews and approval through the governing EC/IRB per country of operation. This provides an important safeguard for the information patients encounter when exploring a trial opportunity.
Our patient-facing materials aim for specific reading levels depending on the audience, to make complex information more accessible while maintaining medical accuracy and consistency with approved content. Questions and explanations also account for the intended patient population, including their age and familiarity with the condition.
For pediatric studies, we simplify language further to suit the children’s ages and use visuals that help engage both children and their parents or caregivers. Materials balance accessible explanations for children with more detailed information about study requirements for the adults supporting them. The atopic dermatitis study leaflet below illustrates this approach:
An atopic dermatitis study leaflet designed by the Clariness Creative Team, for a global sponsor, using clear, age-appropriate language to help families understand the study together.
The attention to clarity extends across countries and languages. We begin with an English master set of materials to country-specific standards and legal requirements, and then translate all materials and variations of them into the languages required. All materials are then reviewed by the relevant local teams to ensure they are appropriate for the local context, use patient-friendly language, which includes verbiage obtained directly from patients as part of our creative process, and that we comply with applicable requirements.
For sponsors, these practices support responsible recruitment by helping patients approach conversations with study teams with clearer information, realistic expectations, and an understanding of their freedom to decide, without burdening patients with complex, medical-first language, with our support teams able to provide technical and medical clarity during patient engagement sessions.
3. A secure digital environment
When patients share information online, the systems that support that interaction matter. ClinLife® uses safeguards designed to protect information against unauthorized access, loss, or misuse.
Regular security testing, access reviews, and internal audits support those safeguards. We also commission independent, third-party penetration testing on an annual basis, with the results regularly provided during sponsor assessments. Defined processes also guide the escalation and investigation of potential privacy or data-security incidents, with responsibilities and timelines for assessment, containment, and required notification.
These activities help turn information security into an ongoing operational responsibility. They also give sponsors evidence to examine when assessing the recruitment services supporting their studies.
4. Quality oversight and trained teams
A consistent patient-facing experience depends on the people and processes behind it. Clariness employees receive role-specific training as part of their onboarding to Clariness, with continuous training provided as refreshers, and whenever processes or requirements change.
Last year’s annual review showed 100% of employees handling patient data had completed all required privacy and data-protection training. Operational teams oversee delivery, while Compliance maintains oversight and checks the effectiveness of implementation controls. Documented procedures cover areas including consent, data subject rights, retention and deletion, information security, and incident handling. A corrective and preventive action process supports the response when issues are identified, and all new clients and projects are given an outline of their escalation paths, both operationally and commercially.
External scrutiny provides another perspective. Across 23 audits and assessments completed in 2025, no critical, major, or minor findings were identified. Outcomes were limited to clarification requests and follow-up questions, with no process changes required. These results provide evidence of the processes supporting our services, alongside the continuing responsibility to maintain and review them.
Building trust form the beginning
For a patient considering a clinical trial, the first interaction may be as simple as reading a study page or answering a few questions. For sponsors, delivering that experience responsibly requires more than the patient-facing interface – it depends on the privacy, study information, communication, security, and quality processes supporting every interaction.
For Clariness, these are practical responsibilities throughout the recruitment journey, as they are concrete areas clients should examine when choosing and reviewing their recruitment partners. For patients, our processes help create an experience in which personal information is respected, and potential trial opportunities can be explored with greater confidence.
Looking for a recruitment partner that puts patient protection into practice? Let’s talk about supporting your next study with clear communication, responsible data handling, and dedicated quality oversight.